APA (7th ed.) Citation

Conley, A. C., Key, A. P., Blackford, J. U., Russell, J. K., Albert, K. M., Gong, X., . . . Newhouse, P. A. Safety, tolerability, pharmacokinetic and pharmacodynamic effects of the muscarinic M1 positive allosteric modulator VU0467319 for Alzheimer’s disease: A single ascending-dose study in healthy participants. BMC.

Chicago Style (17th ed.) Citation

Conley, Alexander C., et al. Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of the Muscarinic M1 Positive Allosteric Modulator VU0467319 for Alzheimer’s Disease: A Single Ascending-dose Study in Healthy Participants. BMC.

MLA (9th ed.) Citation

Conley, Alexander C., et al. Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Effects of the Muscarinic M1 Positive Allosteric Modulator VU0467319 for Alzheimer’s Disease: A Single Ascending-dose Study in Healthy Participants. BMC.